Telix Pharmaceuticals Ltd TLX

Kyahn Williamson — Investor Relations or Communications Officer

Chris Behrenbruch — Chief Executive Officer

Darren Smith — Chief Financial Officer

Kevin Richardson — Commercial or Business Development Executive

Richard Valeix — Research and Development or Clinical Development Executive

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TLX calls or request research access.

More TLX calls Browse calls Request research access